Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1983-2026

Becton Dickinson & Co. recalls BD GasPak EZ Campy Pouch System. Catalog Number: 260685. for microbiologic use

Becton Dickinson & Co.Sparks, MD, United StatesReported May 6, 2026 · 2 months ago
Legal News Analyst ·

Reason for recall

BD identified an issue affecting certain lots of BD GasPak EZ CO2 and BD GasPak EZ Campy Gas Generating Pouch Systems, where gas generating sachets may produce carbon dioxide levels below specification.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

BD GasPak EZ Campy Pouch System. Catalog Number: 260685. for microbiologic use

Lot / code information

Catalog #
260685
UDI
30382902606858
Lot #
5329863

What the firm is doing

On 04/07/2026, BD sent URGENT: Medical Device Correction letters to customers and distributors. Consignees were instructed that there are no recommendations for retrospective chart review or repeat patient testing. They are to verify incubation atmospheres by incorporating the use of appropriate gas indicators as part of routine laboratory quality control practices. Each BD GasPak EZ Gas Generating Pouch System should be tested periodically for its ability to provide adequate conditions for the growth of target organisms. For CO2 incubation, laboratories may use BD CO2 Indicators (Catalog No. 271055), along with the impacted catalog 260684, to verify sufficient CO2 presence in the environment. If conditions are not confirmed or are suspected to be out of specification, laboratories should repeat incubation using alternative validated methods or established laboratory procedures to ensure organism recovery. Additionally, consignees were instructed to ensure the contents of the notification are read and understood, share this notification with the facility network and forward it to any customers to whom product may have been distributed, and complete and return the Customer Response Form. Distributors were instructed to ensure the notification is read and understood, identify all customers that purchased any affected product, and provide a copy of the attached customer letter to all customers who received the affected lots to advise them of this Product Advisory on BD's behalf. BD is investigating the root cause and will implement appropriate corrective actions to prevent recurrence of this issue. BD GasPak catalog numbers 260684 and 260685 are currently on backorder due to seal integrity challenges identified in some batches following a recent overhaul of supplier manufacturing equipment. BD anticipates resumption of product shipments by the end of March 2026, with full recovery expected by June 2026.

DistributionShow details

Worldwide distribution - US Nationwide and the country of Hong Kong.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls